RT @sitcancer: #JITC Research: Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune ch…
438 followers
43 followers
RT @sitcancer: #JITC Research: Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune ch…
19,108 followers
#JITC Research: Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200 https://t.co/toR2Tmf2tO https://t.co/hL6BoLMfOv
438 followers
RT @sitcancer: #JITC Research: Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune ch…